Hemodynamics Study of Enhanced Color Flow Images with Ultrasonic Contrast Agent Levovist in Hepatic Focal Lesions

齐青,王文平,徐智章,季正标,毛枫
DOI: https://doi.org/10.3760/j.issn:1004-4477.2001.04.007
2001-01-01
Abstract:Objective To evaluate the hemodynamic changes of the vascularity in hepatic focal lesions by color Doppler flow imaging techniques after intravenous injection of Levovist.Methods Sixty-one patients with known hepatic masses (a total of 81 nodules, diameter 10~150 mm, mean 52 mm) were examined with color Doppler ultrasonography before and after injection of 2.5 g Levovist(400 mg/ml, once injection for each patient). In the retrospective assessment of the enhancement process, the signal intensity of color flow was graded as 0(absent), I(low), II(medium), III(high), and IV(extensive). Analysis was performed on the vascular transit time, which includes time to arrival, time to peak, time of enhancement duration. These data were compared between benign and malignant lesions.Results Before injection, intratumoral vascularity could be detected in 10(52.6%) of the 19 benign lesions and 34(80.9%) of the 42 malignant lesions, compared to 14(73.6%) and 42(100%) after injection. For benign lesions the time to arrival, time to peak and time of enhancement duration were 37 s, 92 s, 496 s respectively, compared to 29s, 78s, 405s for malignant lesions. The correlation between benign and malignant lesions was statistically significant (P<0.01).Conclusions Enhanced color flow imaging can improve evaluating the vascularity of hepatic focal lesions and aid in differential diagnosis between benign and malignant lesions.
What problem does this paper attempt to address?